Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Public ClinicalTrials.gov record NCT01615120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Protocol G200712 is a Phase II, exploratory study to assess the effects of GTx-758 on serum prostate specific antigen (PSA) response ans serum PSA progression in men with Metastatic Castration Resistant Prostate Cancer (mCRPC) on Androgen Deprivation Therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists, LHRH antagonists, or orchidectomy. This study will also assess the venous thromboembolism (VTE) risk of lower doses of GTx-758.
Study identification
- NCT ID
- NCT01615120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 14, 2012 (Actual)
- Primary completion
- Nov 9, 2016 (Actual)
- Completion
- Nov 9, 2016 (Actual)
- Last update posted
- Mar 24, 2021
2012 – 2016
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Associates Medical Group | Burbank | California | 91505 | — |
| VA of Greater Los Angeles | Los Angeles | California | 90073 | — |
| Tower Urology | Los Angeles | California | 90078 | — |
| San Bernardino Urological Assoc. | San Bernardino | California | 92404 | — |
| Genesis Healthcare Partners | San Diego | California | 92123 | — |
| Urology Specialists of So. California | Torrance | California | 90505 | — |
| Univ. of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Connecticut Clinical Research Center | Middlebury | Connecticut | 06762 | — |
| So. Florida Medical Research | Aventura | Florida | 33180 | — |
| AMPM Research | Miami | Florida | 33145 | — |
| Coastal Medical Center | Sarasota | Florida | 34237 | — |
| GTx Investigative Site | St. Petersburg | Florida | 33710 | — |
| Pinellas Urology | St. Petersburg | Florida | 33710 | — |
| Urology of Indiana | Greenwood | Indiana | 46143 | — |
| First Urology PSC | Jeffersonville | Indiana | 47130 | — |
| Chesapeake Urology Research Assoc. | Towson | Maryland | 21204 | — |
| Five Valleys Urology | Missoula | Montana | 59808 | — |
| Urological Institute of NE New York | Albany | New York | 12208 | — |
| AMP of NY | Oneida | New York | 13421 | — |
| AMP of NY | Syracuse | New York | 13210 | — |
| Carolina Clinical Trials | Concord | North Carolina | 28025 | — |
| The Urology Group | Cincinnati | Ohio | 45212 | — |
| UCSEPA | Bala-Cynwyd | Pennsylvania | 19004 | — |
| West Clinic | Memphis | Tennessee | 38119 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
| Seattle Cancer Care Alliance, Univ. of Washington | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01615120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01615120 live on ClinicalTrials.gov.